Head to head for first-timers
CoreAge Rx vs MultiMedRx
CoreAge Rx and MultiMedRx both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxMultiMedRx
Rank #303 for first-timers · Grade C
Mama-Match
Best for: There is no way to say without a medication price, and the site does not give one.
Visit MultiMedRxThe verdict for a first step
CoreAge Rx edges out MultiMedRx on the Mama-Match Score, 94 to 35 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
MultiMedRx is still a genuine option — there is no medication price on this site. The $100 is "the $100 fully refundable consultation fee" and the "$45 to start" is an entry promotion; the program fee — the one that actually pays for the medication — is described in the FAQ and never stated. What it does say clearly is the billing period: the "(4-Week monthly) program fee", four weeks and monthly in the same phrase, which is thirteen charges a year rather than twelve. And if you ask about states, it sends you to the intake form. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | MultiMedRx |
|---|---|---|
| Mama-Match Score | 94/100 · A | 35/100 · C |
| Overall rank | #1 | #303 |
| Semaglutide | $99/mo | No medication price published at all |
| Tirzepatide | $149/mo | No medication price published at all |
| Coverage | All 50 states | Refuses to publish it: "complete the patient intake form" |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
MultiMedRx
Rank #303 · Grade C
What we like
- The $100 consultation fee is described as fully refundable, and said up front
- It does say what the program fee covers: medication "up to 10ml for Tirzepatide and 2.5 for Semaglutide"
- "You don't need to sign a long-term contract", with a one-month option
The caveats
- No medication price appears anywhere: the program fee is described but never stated
- The $100 is a consultation fee and the $45 a promotion; neither is a monthly cost
- The billing period is four weeks, not a month — its own phrase is "(4-Week monthly) program fee", so thirteen cycles a year
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and MultiMedRx with the other providers we review for women.
Or browse the full comparison hub.